Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells. 1993

B Lucas, and A Engel, and D Camus, and A Haque
Centre d'Immunologie et de Biologie Parasitaire, Institut Pasteur, Lille, France.

Mice infected with Plasmodium yoelii (265 BY, a nonlethal strain) after recovering from parasitemia become resistant to reinfection. In the present study, we have attempted to define the role of T cell subsets in primary vs secondary P. yoelii infection. We have evaluated the in vivo effects of selective depletion of each subset of T cells on the course of infection and also investigated the in vitro expansion of each subset in response to homologous antigen. Depletion of CD4- or CD8-bearing T cells did not result in reappearance of parasitemia in animals cured from primary infection. However, 25% of reinfected animals treated with anti-CD4 mAb, but not with anti-CD8 mAb, displayed a low level (2 to 3%) of parasitemia late in the secondary infection. The splenocyte response to P. yoelii antigen or to T-cell mitogens was impaired during patient infection, even in the 25% of CD4-depleted animals with low parasitemia. A markedly high lymphocyte reactivity to antigen was observed in mice recovered from primary infection, and this was enhanced in animals exposed to a challenge infection. In the case of animals cured from primary infection, a marked decrease in antigen-induced in vitro lymphocyte proliferation occurred in CD8-depleted but not in CD4-depleted animals when total splenic cell populations were assayed. Although less dramatic, a significant diminution in antigen reactivity was observed also with T-rich populations in CD8-depleted animals. In contrast, there was no such decrease in CD4-depleted mice. Treatment of resistant animals which were challenged with a second infection, with anti-CD4 or anti-CD8 mAbs, resulted in a significant decrease in the proliferative response to antigen by both T-rich and total cell populations. In the secondary infection, the T-rich cell populations from CD8-depleted mice responded better to P. yoelii antigen than the total cell populations, indicating an inhibitory role on the expansion of CD4+ T cells of B cells or their product(s) which were removed during T cell enrichment. The results of our study suggest that CD8-bearing T cells were more reactive in the primary infection. In the secondary infection, although both CD8+ and CD4+ T cells were antigen reactive, the latter T cell subset appeared to play a superior role in controlling the parasitemia.

UI MeSH Term Description Entries
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010967 Plasmodium yoelii A species of PLASMODIUM causing malaria in rodents. Plasmodium yoelius,yoelius, Plasmodium
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

B Lucas, and A Engel, and D Camus, and A Haque
April 1990, European journal of immunology,
B Lucas, and A Engel, and D Camus, and A Haque
April 1994, Cancer immunology, immunotherapy : CII,
B Lucas, and A Engel, and D Camus, and A Haque
April 2007, Molecular immunology,
B Lucas, and A Engel, and D Camus, and A Haque
January 2013, PloS one,
B Lucas, and A Engel, and D Camus, and A Haque
September 2009, Parasitology,
B Lucas, and A Engel, and D Camus, and A Haque
September 2001, Parasitology international,
B Lucas, and A Engel, and D Camus, and A Haque
February 1990, Clinical and experimental immunology,
B Lucas, and A Engel, and D Camus, and A Haque
April 2014, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!